Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Dow
Merck
Colorcon
Covington
UBS
Teva
QuintilesIMS
Fuji

Generated: June 22, 2018

DrugPatentWatch Database Preview

PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Pioglitazone Hydrochloride And Glimepiride patents expire, and when can generic versions of Pioglitazone Hydrochloride And Glimepiride launch?

Pioglitazone Hydrochloride And Glimepiride is a drug marketed by Sandoz and is included in one NDA.

The generic ingredient in PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE is glimepiride; pioglitazone hydrochloride. There are fifteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glimepiride; pioglitazone hydrochloride profile page.
Summary for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
Drug patent expirations by year for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
Synonyms for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
834894-07-4
Glimepiride mixture with Pioglitazone HCl
Glimepiride mixture with Pioglitazone hydrochloride
LS-187965
SCHEMBL3967853
Tandemact

US Patents and Regulatory Information for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE glimepiride; pioglitazone hydrochloride TABLET;ORAL 201049-001 Jan 4, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE glimepiride; pioglitazone hydrochloride TABLET;ORAL 201049-002 Jan 4, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Accenture
Healthtrust
Fuji
Cerilliant
Argus Health
Cantor Fitzgerald
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.